GSK - 22 "SPLAV", Moscow Oblast

Economic indicators

Net loss (RAS) of GSK - 22 SPLAV increased by 9.68% to 2.64 million RUB from 2.41 million RUB over 2022, the company informed.

Revenue remained in the accounting period at the same level and made up 120.00 thousand RUB compared to 120.00 thousand RUB 120.00 thousand RUB; cost of goods sold grew by 5.03% to 2.96 million RUB from 2.82 million RUB; sales loss grew by 5.26% to 2.84 million RUB from 2.70 million RUB.

Net loss (RAS) of GSK - 22 SPLAV dropped over 2022 by 12.03% to 2.41 million RUB from 2.74 million RUB KAgent.Entities.Balance, the company informed.

Revenue decreased in the accounting period by 27.71% to 120.00 thousand RUB from 166.00 thousand RUB in 2021; cost of goods sold decreased by 10.61% to 2.82 million RUB from 3.16 million RUB; sales loss decreased by 9.66% to 2.70 million RUB from 2.99 million RUB.

Net loss (RAS) of GSK - 22 SPLAV increased 1.66 times to 2.74 million RUB from 1.64 million RUB over 2020, the company informed.

Revenue increased in the accounting period by 24.81% to 166.00 thousand RUB from 133.00 thousand RUB over 2020; sales loss grew 1.64 times to 2.99 million RUB from 1.82 million RUB.

Net loss (RAS) of GSK - 22 SPLAV dropped over 2020 by 23.65% to 1.64 million RUB from 2.15 million RUB KAgent.Entities.Balance, the company informed.

Revenue increased in the accounting period by 23.15% to 133.00 thousand RUB from 108.00 thousand RUB over 2019; sales loss decreased by 22.07% to 1.82 million RUB from 2.33 million RUB.

Companies in the region

• MBOU SOSH N9
• GSK - 14
• TSZH "LUCH"
• PAK LUGOVSKAYA PROIZVODSTVENNO-AGRARNAYA KOMPANIYA LUGOVSKAYA
• RTI